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The Hodgkin-Huxley formulation, at its 60th anniversary, remains a bastion of neuroscience. Sodium chan-
nels Nav1.1–Nav1.3 and Nav1.6–Nav1.9 support electrogenesis in neurons and are often considered
‘‘neuronal,’’ whereas Nav1.4 and Nav1.5 drive electrogenesis in skeletal and cardiac muscle. These channels
are, however, expressed in cell types that are not considered electrically excitable. Here, we discuss sodium
channel expression in diverse nonexcitable cell types, including astrocytes, NG2 cells, microglia, macro-
phages, and cancer cells, and review evidence of noncanonical roles, including regulation of effector func-
tions such as phagocytosis, motility, Na+/K+-ATPase activity, and metastatic activity. Armed with powerful
techniques for monitoring channel activity and for real-time assessment of [Na+]i and [Ca
2+]i, neuroscientists
are poised to expand the understanding of noncanonical roles of sodium channels in healthy and diseased
tissues.In Brief
Sodium channels support electrogenesis in neurons and skeletal
and cardiac muscle. They are, however, expressed in cell types
that are not considered electrically excitable, including astro-
cytes, NG2 cells, microglia, macrophages, and cancer cells,
where they regulate phagocytosis, motility, Na+/K+-ATPase
activity, and metastatic activity.
We have now passed the 60th anniversary of the Hodgkin and
Huxley (1952) discovery of the role of sodium channels in electro-
genesis, and it remains a bastion of modern neuroscience:
voltage-gated sodium channels are major players in action-
potential electrogenesis. Seven of the voltage-gated sodium
channels (Nav1.1–Nav1.3 and Nav1.6–Nav1.9) play major
roles in electrogenesis in neurons and are often considered
‘‘neuronal,’’ whereas Nav1.4 is the muscle sodium channel and
Nav1.5 is the predominant cardiacmyocyte channel. The canon-
ical role of sodium channels in impulse electrogenesis and con-
duction in these excitable cells has been well established and is
relatively well understood (see Rush et al., 2007; Catterall, 2012).
Indeed, major aspects of the pathophysiology of neurological
disorders, including epilepsy (George, 2004; Helbig et al.,
2008; Reid et al., 2009; Eijkelkamp et al., 2012; Oliva et al.,
2012), multiple sclerosis (MS) (Waxman, 2006), peripheral neu-
ropathy (Faber et al., 2012a,2012b), neuropathic pain (Wood,
2007; Dib-Hajj et al., 2010,2013), muscle diseases such as myo-
tonic dystrophy (Jurkat-Rott et al., 2010; Stunnenberg et al.,
2010) and periodic paralysis (Cannon 2010), and cardiac disor-
ders such as Brugada syndrome (Campuzano et al., 2010;
Song and Shou, 2012; Tarradas et al., 2013), can be attributed
to abnormalities of electrical excitability due to sodium channel
dysfunction. Nonetheless, beyond the expression of sodium
channels in neurons, myocytes, cardiomyocytes, and other
excitable cells, there is convincing evidence that multiple sub-
types of voltage-gated sodium channels—the same channels
that support electrogenesis in nerve cells, muscle cells, and car-
diacmyocytes—are expressed and play major functional roles in
cell types that have been traditionally considered to be nonexcit-280 Neuron 80, October 16, 2013 ª2013 Elsevier Inc.able (termed here ‘‘nonexcitable cells’’). Moreover, there is abun-
dant evidence demonstrating that sodium channels participate
in or regulate multiple effector functions in these nonexcitable
cells. It is becoming clear, for example, that sodium chan-
nels—located not only on the plasma membrane delimiting the
cell from the extracellular space but also, in some cases, on
intracellular membranes surrounding specific organelles within
the cell—contribute to processes as diverse as phagocytosis,
motility, the release of bioactive molecules, and the regulation
of Na+/K+-ATPase activity in nonneuronal cells, including cells
as disparate as microglia and astrocytes within the CNS, where
they participate in the response to CNS injury, and cancer cells,
where they contribute tomotility and invasiveness. The neurosci-
ence community, which has a long history of discoveries on
sodium channels and their function and which possesses an
armamentarium of powerful tools that can help explicate the
function of sodium channels, is in a unique position to elucidate
the functions of sodium channels in nonexcitable cells, as well as
in neurons. In this article, we discuss the expression of sodium
channels in nonexcitable cells and review accumulating evi-
dence showing that, within these cells, these channels play
noncanonical roles and participate in multiple, diverse effector
functions.
Sodium Channels Are Expressed in Nonexcitable Cells
It is now known that nine different genes encode nine distinct
sodium channels (Nav1.1–Nav1.9), which are expressed with
diverse temporal and regional patterns in excitable cells (Catter-
all et al., 2005) and are variably associated with b-subunits
(Patino and Isom, 2010; Brackenbury and Isom, 2011). Although
all voltage-gated sodium channels share a common overall
structural motif and considerable homology, the different sub-
types display distinct voltage dependence and kinetic and phar-
macological properties (Catterall et al., 2005), and the repertoire
of sodium channel subtypes expressed in a particular type of
excitable cell significantly contributes to its pattern of electrores-
ponsiveness (see, e.g., Waxman 2000; Rush et al., 2007).
Table 1. Voltage-Gated Sodium Channels in Nonexcitable Cells
Cell type Sodium Currents or Channels References
Astrocytes TTX-S, TTX-R currents; Nav1.2,
Nav1.3, Nav1.5, Nav1.6
Bevan et al., 1985, 1987; Nowak et al., 1987; Barres et al., 1988; Sontheimer
et al., 1991, 1992, 1994; Sontheimer and Waxman, 1992; Thio and Sontheimer,
1993; Black et al., 1995a, 1998, 2010; Kressin et al., 1995; Bordey and
Sontheimer, 1998; Reese and Caldwell, 1999
Cancer cells Nav1.4, Nav1.5, Nav1.6, Nav1.7 Fraser et al., 2003, 2005; Roger et al., 2003; Diss et al., 2004, 2005; Brackenbury
and Djamgoz, 2006; Gillet et al., 2009; Yang et al., 2012
Chrondrocytes TTX-S Sugimoto et al., 1996
Dendritic cells Nav1.7 Zsiros et al., 2009; Kis-Toth et al., 2011
Endothelial cells TTX-S, TTX-R currents; Nav1.4,
Nav1.5, Nav1.6
Gordienko and Tsukahara, 1994; Gosling et al., 1998;Walsh et al., 1998;
Traub et al., 1999
Fibroblasts TTX-S, TTX-R; Nav1.2, Nav1.3,
Nav1.5, Nav1.6, Nav1.7
Munson et al., 1979; Estacion 1991; Li et al., 2009; Chatelier et al., 2012
Keratinocytes Nav1.1, Nav1.6, Nav1.8 Zhao et al., 2008
Islet b-cells TTX-S; Nav1.2, Nav1.3 Donatsch et al., 1977; Pressel and Misler, 1991; Philipson et al., 1993; Barnett
et al., 1995; Eberhardson and Grapengiesser, 1999
Macrophages TTX-S current; Nav1.5, Nav1.6 Schmidtmayer et al., 1994; Carrithers et al., 2007, 2009, 2011; Black et al., 2013
Microglia TTX-S current; Nav1.1, Nav1.5,
Nav1.6
Korotzer and Cotman, 1992; No¨renberg et al., 1994; Craner et al., 2005; Black
et al., 2009; Nicholson and Randall, 2009
Mu¨ller glia TTX-S, TTX-R currents; Nav1.6,
Nav1.9
Chao et al., 1994; Francke et al., 1996; O’Brien et al., 2008; Linnertz et al., 2011
Odontoblasts Nav1.2 Allard et al., 2006
Oligodendrocyte precursor
cells (NG2+)
TTX-S current Bevan et al., 1987; Williamson et al., 1997; Chen et al., 2008; Ka´rado´ttir et al.,
2008; Tong et al., 2009
Osteoblasts Nav1.2 Black et al., 1995b
Red blood cells Nav1.4, Nav1.7 Hoffman et al., 2004
Schwann cells TTX-S current; Nav1.2, Nav1.3 Chiu et al., 1984; Howe and Ritchie, 1990; Oh et al., 1994
T lymphocytes TTX-S, TTX-R currents; Nav1.5 DeCoursey et al., 1985, 1987; Lai et al., 2000; Fraser et al., 2004; Lo et al., 2012
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peripheral neurons, whereas Nav1.7–Nav1.9 are preferentially
expressed in peripheral neurons (Beckh et al., 1989; Felts
et al., 1997; Gong et al., 1999; Schaller and Caldwell, 2003; Cat-
terall et al., 2005; Dib-Hajj et al., 2013). Nav1.3 is present in the
adult human brain (Chen et al., 2000; Whitaker et al., 2001; Thim-
mapaya et al., 2005), but it is predominantly expressed during
embryonic and early postnatal periods in rodents. Nav1.3 is
upregulated in dorsal root ganglion neurons in adult rodents after
nerve injury (Waxman et al., 1994; Black et al., 1999) and contrib-
utes to hyperexcitability of these cells and thus neuropathic pain
(Cummins and Waxman, 1997; Samad et al., 2013). Nav1.4 is
predominantly expressed in skeletal muscle (Barchi et al.,
1984; Trimmer et al., 1989), whereas Nav1.5 is the principal
sodium channel in cardiac muscle (Gellens et al., 1992; Clancy
and Kass 2002; Fozzard 2002).
Early evidence of voltage-dependent sodium currents attribut-
able to sodium channels in nonexcitable cells was provided by
patch-clamp studies on cultured Schwann cells and astrocytes
(Chiu et al., 1984; Bevan et al., 1985), which, when held
at 100 mV and then stepped to +40 mV in 10 mV steps, ex-
hibited a family of fast-activating, fast-inactivating traces that
could be blocked with the sodium-channel-specific ligands
tetrodotoxin (TTX) and saxitoxin (STX). Subsequent to these
early studies, a wide variety of nonexcitable cells, ranging fromglial and immune cells to endothelial and cancer cells, had
been shown to express voltage-gated sodium currents, and it
has been shown that nonexcitable cells can express multiple
sodium channel subtypes (Table 1).
Patch-clamp recordings have confirmed the expression of
functional sodium channels in cell types as divergent as astro-
cytes (Barres et al., 1988; Sontheimer et al., 1992; Sontheimer
and Waxman, 1992), oligodendrocyte precursor cells (Son-
theimer et al., 1989; Kettenmann et al., 1991; Kressin et al.,
1995; Chen et al., 2008; Ka´rado´ttir et al., 2008), Schwann cells
(Howe and Ritchie, 1990), fibroblasts (Estacion 1991; Li et al.,
2009), breast and prostate cancer cells (Fraser et al.,
2003,2005; Roger et al., 2003; Brackenbury and Djamgoz,
2006; Ding et al., 2008; Gillet et al., 2009), and macrophages
and microglia (Korotzer and Cotman, 1992; No¨renberg et al.,
1994; Schmidtmayer et al., 1994), including a microglial cell
line derived from the human CNS (Nicholson and Randall,
2009). These recordings provide a precise measure of current
density (and can thus be used for estimating the density of
functional channels in the cell membrane) and can distinguish
the expression of sodium channels that are sensitive to
nanomolar levels of TTX (TTX-S; Nav1.1–Nav1.4, Nav1.6, and
Nav1.7) from that of a group of TTX-resistant (TTX-R) channels,
which require micromolar concentrations of TTX for blockade
(Nav1.5, Nav1.8, and Nav1.9). RT-PCR, in situ hybridization,Neuron 80, October 16, 2013 ª2013 Elsevier Inc. 281
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the molecular identities of sodium channel a-subunits in nonex-
citable cells and have shown the expression of every sodium
channel subtype in some type of nonexcitable cell (e.g., Black
et al., 1998; Diss et al., 1998; Zhao et al., 2008; Zsiros et al.,
2009). Within some cell types, only a single subtype has been
detected (e.g., Nav1.7 in dendritic cells; Zsiros et al., 2009),
whereas other cell types have been shown to express multiple
subtypes; for instance, astrocytes have been shown to express
Nav1.2, Nav1.3 (Black et al., 1995a), Nav1.5 (Black et al.,
1998), and Nav1.6 (Reese and Caldwell, 1999), and microglia
have been shown to express Nav1.5 and Nav1.6 (Craner et al.,
2005; Black et al., 2009). Human red blood cells have been
shown to express Nav1.4 and Nav1.7 (Hoffman et al., 2004).
Although this article focuses on the Nav1.1–Nav1.9 pore-forming
a-subunits of sodium channels, there is also evidence demon-
strating the presence of sodium channel b-subunits in some
nonexcitable cells (Oh and Waxman, 1994), where they are
postulated to function as cell-adhesion molecules (Brackenbury
et al., 2010).
As described below, voltage-gated sodium channels con-
tribute to diverse effector functions of nonexcitable cells. This
is all the more remarkable because, in general, estimated den-
sities of sodium channels in nonexcitable cells are substantially
lower than those in excitable cells (<1 versus 2–75 mm2, respec-
tively; see, e.g., Sontheimer et al., 1992). Spinal cord astrocytes
in vitro are an exception and can express sodium channels at
densities estimated to be as high as 10 channels per mm2
(Sontheimer et al., 1992), which, although not supporting action
potential electrogenesis close to resting potential, can support
the production of all-or-none overshooting action-potential-like
responses when the cells are hyperpolarized to levels that
remove resting inactivation (Sontheimer and Waxman, 1992).
The density of sodium channels in cells such as astrocytes
in vitro depends on the milieu to which the cells are exposed
(Thio and Sontheimer, 1993; Thio et al., 1993), raising the ques-
tion of whether channel expression is an artifact of culture.
Importantly, however, astrocytes within slices of hippocampus,
cerebral cortex, spinal cord, and cerebellum also express
sodium currents (Sontheimer and Waxman, 1993; Chva´tal
et al., 1995; Bordey and Sontheimer, 2000). Thus, expression
of these channels within astrocytes can occur within a relatively
normal milieu and is not an artifact of culture. Further confirma-
tion of this comes from immunocytochemical studies that have
demonstrated the expression of sodium channels in astrocytes
in situ within both the rodent (Black et al., 1994, 1998) and the
human (Black et al., 2010) brain.
Sodium Channel Expression in Nonexcitable Cells Is
Dynamic
The expression of sodium channels in nonexcitable cells is not
static and, on the contrary, may change markedly depending
on the developmental and/or physiological state of the cells.
For instance, differentiation of cells of the oligodendrocyte line-
age, from oligodendrocyte precursor cells (OPCs) to mature
myelinating oligodendrocytes, is accompanied by switches in
patterns of phenotypic expression (see Levine et al., 2001),
including the downregulation of sodium channels (Paez et al.,282 Neuron 80, October 16, 2013 ª2013 Elsevier Inc.2009). OPCs express robust voltage-sensitive sodium currents.
In contrast, sodium currents are smaller and present in only a
subpopulation of more differentiated O4+ cells and are absent
in mature oligodendrocytes (Sontheimer et al., 1989). The
expression of sodium channels in OPCs may have important
physiological consequences. It is known that action potential
activity can lead to vesicular glutamate release at discrete sites
along axons, and this can activate ionotropic glutamate recep-
tors on neighboring OPCs (Kukley et al., 2007). Eighty-one
percent of OPCs that express sodium channels respond to this
type of neurotransmitter release, whereas only 2% of OPCs
that lack sodium channel expression show these responses,
suggesting that the ability of OPCs to respond to axonal
signaling may be associated with the expression of sodium
channels within these cells (Ka´rado´ttir et al., 2008). In fact, it
has been hypothesized that the activity of these channels may
trigger myelination by these cells (Ka´rado´ttir et al., 2008). One
possible mechanism is that expression of sodium channels in
OPCs participates in setting their resting membrane potential,
and this, in turn, may contribute to controlling their rate of prolif-
eration (Xie et al., 2007).
Switches in sodium current expression are not confined to
healthy nonexcitable cells but have also been reported after
pathological challenge. For example, in an in vitro model of
astrogliosis in which a confluent layer of cultured rat astrocytes
was scratched for the production of a linear injury, the injury
evoked a switch from TTX-S currents to TTX-R sodium currents
(MacFarlane and Sontheimer, 1998). Consistent with the change
in sodium currents, markedly upregulated expression of the
TTX-R sodium channel, Nav1.5, was recently reported in reac-
tive astrocytes at the boundary of the scar injury in this in vitro
model (Samad et al., 2013). Importantly, upregulation of sodium
channels in reactive astrocytes occurs in situ within the human
brain. Observations on rapid-autopsy tissues demonstrate
robust upregulation of Nav1.5, which is not seen in normal con-
trol brains, within scarring astrocytes in acute and chronic MS
plaques and adjacent to cerebrovascular accidents and neo-
plastic lesions in the human brain (Black et al., 2010; Figure 1).
Astrocytes are not the sole nonexcitable cell type that displays
a switch in sodium channel expression after pathological insult.
The differentiation of human fibroblasts into myofibroblasts
under pathological conditions is accompanied by de novo
Nav1.5 expression (Chatelier et al., 2012) similar to that exhibited
by reactive astrocytes. Mu¨ller cells, the primary macroglial cells
in the retina, where they provide functional and metabolic sup-
port to neighboring neurons (Bringmann and Wiedemann,
2012), also exhibit increased sodium channel expression in
response to injury (e.g., glaucoma, melanoma, retinal detach-
ment) in that they express 4-fold larger sodium currents than
do Mu¨ller cells from normal retinas (12.2 versus 3.0 pA/pF,
respectively; Francke et al., 1996).
Sodium Channels Participate in Multiple Effector
Functions of Nonexcitable Cells
Several lines of evidence have demonstrated that sodium chan-
nels contribute to multiple, diverse cellular functions in nonexcit-
able cells (Table 2). In many cases, a functional role has
been demonstrated on the basis of pharmacological blockade,
Figure 1. Nav1.5 Expression in Astrocytes
within MS Tissue
A montage of gray-scale images of R. communis
agglutinin I (RCA-1)-positive macrophages (white)
in a section of MS tissue was constructed to
provide orientation for localization of astrocytes. A
region of substantial macrophage infiltration is
present in the lower three-quarters of the field. An
adjacent serial section was labeled for Nav1.5
(red), GFAP (green), and PLP (blue), and high-
magnification images corresponding to the boxed
numbers in the montage are shown in the right-
hand panels. A GFAP-positive astrocyte within
normal-appearing white matter (NAWM), which is
not in the montage field, exhibited limited Nav1.5
immunolabeling. In contrast, an astrocyte (panel 1)
within white matter, which is more disrupted than
NAWM, and 250 mm from the plaque border was
hypertrophic and showed an upregulation of
Nav1.5. Astrocytes at the border (panel 2) and
within (panel 3) the active lesion displayed intense
Nav1.5 immunolabeling. Colocalization of GFAP
and Nav1.5 is shown in yellow. (Modified from
Figure 7 in Black et al., 2010).
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demonstrated that sodium channel blockade with TTX attenu-
ates phagocytosis by 40% in cultured microglia. They also
showed that the phagocytic capacity of microglia derived from
med mice, which lack Nav1.6 channels (Kohrman et al., 1996),
is 65% lower than that of microglia from wild-type (WT) mice.
Black et al. (2009) observed that the clinically used sodium chan-
nel blocker phenytoin significantly reduces the phagocytic
activity of microglia by 50%–60% (Figure 2). These studies
also showed that TTX and phenytoin attenuate the release of
the proinflammatory cytokines interleukin 1-a (IL-1a), IL-1b,
and tumor necrosis factor a (TNF-a) from stimulated microglia
while having minimal effects on the release of IL-2, IL-4, IL-6,
IL-10, monocyte chemotactic protein 1 (MCP-1), and transform-
ing growth factor a (TGF-a). Phenytoin and TTX also significantly
decrease ATP-induced migration of microglia. Supporting a role
for Nav1.6 in the pathway leading to microglial migration, the
level of ATP-induced migration of microglia cultured from med
mice is significantly lower than that of cells from littermate WT
mice (Black et al., 2009).
Another line of evidence of a novel contribution of sodium
channels—in this case the ‘‘cardiac’’ Nav1.5 channel—to the
function of nonexcitable cells was provided by Carrithers et al.
(2007), who demonstrated the expression of Nav1.5 within phag-
osomes of activated human macrophages by immunocyto-
chemistry and immunogold electron microscopy (Figure 3). The
expression of Nav1.5 was restricted to late endosomes of these
cells and was not detected in early endosomes or on the macro-Neuron 80phage plasma membrane. Evidence of a
role for Nav1.5 in macrophage function
was provided by the demonstration that
TTX at 10 mM (a concentration that blocks
Nav1.5) and gene knockdown of Nav1.5
with small hairpin RNA (shRNA) inhibit
phagocytosis by these cells. Using time-
resolved fluorometry, Carrithers et al.(2007) also demonstrated that the sodium channel activator
veratridine reduces intraendosomal pH and intraendosomal
[Na+] and that 10 mM TTX blocks lipopolysaccharide-induced
acidification of the intraendosomal compartment in both purified
endosomes and intact macrophages. These results suggest a
model in which Nav1.5 channels, located intracellularly within
the membrane of late endosomes, provide a route for Na efflux,
which counterbalances proton influx, and thereby maintain elec-
troneutrality during acidification, which is one of the final stages
of phagocytosis. Noting that pH regulates the current of Nav1.5
(Khan et al., 2006), Carrithers et al. (2007) suggested that the
expression and activity of Nav1.5 on the intracellular endosomal
membrane may provide a regulatory loop in which, as intraendo-
somal pH decreases toward a functional optimum in the late
endosome, the endosomal sodium channels become inactive,
limit further acidification, and thus prevent cell injury. Extending
these observations to human tissue, Black et al. (2013) recently
demonstrated the expression of Nav1.5 in late, but not early,
endosomes in phagocytosing macrophages within acute MS
lesions.
Still another example of a role for sodium channels in the regu-
lation of effector functions of nonexcitable cells is provided by
dendritic cells (DCs), the antigen-presenting immune cells that
function as intermediaries between innate and adaptive immu-
nity. Immature monocyte-derived DCs express Nav1.7 chan-
nels, but the expression of these channels is attenuated during
maturation (Zsiros et al., 2009). Even if it did not result in a
large increase in intracellular [Na+], the addition of even a small, October 16, 2013 ª2013 Elsevier Inc. 283
Table 2. Sodium Channel Contributions to Effector Functions
Cell Type Sodium Channel Blockade or Activation References
Astrocytes TTX: attenuates Na+/K+-ATPase activity and increases
cell death
Sontheimer et al., 1994
Cancer cells TTX, phenytoin, Nav1.5 siRNA: attenuate motility,
migration, invasiveness, metastasis, and extracellular
acidification
Fraser et al., 2003, 2005; Roger et al., 2003; Brackenbury
et al., 2007; Brackenbury and Djamgoz, 2006; Gillet et al.,
2009; Yang et al., 2012; Yildirim et al., 2012
Dendritic cells (CD1a+) TTX, Nav1.7 siRNA: inhibit cell migration and sensitize
cells for activation
Kis-Toth et al., 2011
Endothelial cells TTX: potentiates shear-stress-induced ERK1/2
activation
Traub et al., 1999
Islet b-cells TTX: attenuates insulin release Donatsch et al., 1977; Pressel and Misler, 1991
veratridine: increases insulin release
Keratinocytes TTX: inhibits ATP release Zhao et al., 2008
Macrophages TTX, Nav1.6 shRNA: attenuate phagocytosis and
invasion and inhibit podosome formation
Carrithers et al., 2007, 2009
Nav1.5 siRNA: attenuates endosomal acidification
veratridine: increases endosomal acidification
Microglia TTX, phenytoin: attenuate phagocytosis, migration,
cytokine release
Craner et al., 2005; Black et al., 2009
Oligodendrocyte precursor
cells (NG2+)
TTX, Nav1.x siRNA: attenuate ligand-induced migration Tong et al., 2009
Retinal Mu¨ller cells TTX, STX, phenytoin: inhibit ligand-induced release
of glutamate
Linnertz et al., 2011
T lymphocytes TTX: inhibits migration Fraser et al., 2004
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activation of a small fraction of available channels) would be
expected to have a depolarizing effect on resting potential of
these cells. A link between Nav1.7 expression and cell function
in DCs is suggested by the observation that Nav1.7 current
density is significantly greater in CD1a+ immature DCs than in
CD1a immature DCs (Kis-Toth et al., 2011). The presence of a
Nav1.7 current is associated with a depolarized resting mem-
brane potential, as predicted by the Goldman-Hodgkin-Katz
equation, in CD1a+ DCs, and blockade or knockdown of
Nav1.7 in these cells yields a hyperpolarization of the resting
membrane potential, which is associated with attenuated
mobility and gene expression of matrix metalloproteinase 12
(Kis-Toth et al., 2011). Nav1.7 blockade with TTX also attenuates
inflammatory-cytokine-stimulated activation of CD1a+ DCs and
the release of TNF-a and IL-10 from these cells.
There is also increasing evidence suggesting that levels of
sodium channel expression are correlated with invasiveness
and metastatic potential in several types of cancer cells.
For example, strongly metastatic breast cancer cells express
voltage-sensitive sodium currents, whereas weakly metastatic
and normal breast epithelial cells do not (Fraser et al., 2005;
Yang et al., 2012). Upregulated expression of a neonatal splice
form of Nav1.5 has been linked to strong metastatic potential
in vitro and breast cancer progression, and there appears to
be a correlation between Nav1.5 expression and clinically
assessed lymph node invasion (Fraser et al., 2005). Levels of
sodium channel expression are also greater in prostate biopsies
from patients with cancer than in non-cancer biopsies (Diss
et al., 2005). Sodium channel activity has been reported to284 Neuron 80, October 16, 2013 ª2013 Elsevier Inc.potentiate the effect of epidermal growth factor (EGF), which
enhances the migration and invasiveness of prostate cancer
cells (Uysal-Onganer andDjamgoz, 2007), suggesting a potential
mechanism linking sodium channel activity to metastatic activity
in these cells. In this regard, it has been demonstrated that
sodium channel activity in MDA-MB-231 breast cancer cells
leads to intracellular alkalinization and pericellular acidification,
which promotes the activity of released proteolytic enzymes
and cell invasiveness (Gillet et al., 2009). At present, the molec-
ular pathway(s) by which sodium channel activity participates in
the regulation of intracellular and extracellular pH of cancer cells
is not known, but it has been suggested to involve interactions
with the sodium-proton exchanger, bicarbonate transporters,
vacuolar H+-ATPase, and/or monocarboxylate transporters (Gil-
let et al., 2009). Sodium channel activity is also likely to affect
cancer cells’ membrane potential, which has been linked to their
proliferation and migration (Yang and Brackenbury, 2013). In
in vitro assays of cancer cell invasiveness, blockade, or knock-
down of sodium channels with TTX, phenytoin or small inter-
fering RNA (siRNA) has been shown to significantly attenuate
directional motility and cell migration (Roger et al., 2003; Fraser
et al., 2005; Brackenbury et al., 2007; Brackenbury, 2012;
Yang et al., 2012). At the in vivo level, it has been reported in a
rat model of prostate cancer that blocking sodium channel activ-
ity with TTX reduces the number of lung metastases by 40% and
significantly prolongs lifespan (Yildirim et al., 2012). Whether
targeted sodium channel blockade or knockdown can contribute
to cancer treatment is not yet known, but higher levels in more
metastatic cells suggest these channels as potential biomarkers
(Diss et al., 2005).
Figure 2. Sodium Channel Blockade Inhibits Microglial Phagocytosis
Lipopolysaccharide (LPS)-stimulated microglia (red) in vitro exhibited substantial phagocytosis of fluorescent-labeled latex beads. Incubation with tetrodotoxin
(TTX) and phenytoin (phen) attenuated phagocytosis of latex beads by LPS-activated microglia. (Modified from Figure 2A in Black et al., 2009).
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PerspectivePathways of Sodium Channel Activity Regulating Cell
Function
Although it is clear that sodium channels participate in or regu-
late multiple functions within a spectrum of nonexcitable cell
types, we presently have only hints about the underlying molec-
ular mechanism(s). Extrapolating from the small number of cell
types in which mechanisms linking sodium channels to cell func-
tion have been studied, it seems likely, in fact, that sodium chan-
nels affect physiological responses of cells by multiple pathways
(Figure 4). In a study on astrocytes, Sontheimer et al. (1994) sug-
gested a mechanism in which sodium channels provide a route
for a small sustained Na+ influx, which is necessary for continued
operation of Na+/K+-ATPase. In these cells, sodium channel
blockade with TTX attenuates Na+/K+-ATPase activity, reduces
astrocyte [Na+]I, and with prolonged exposure, leads to cell
death. This cascade, in which voltage-gated channels provide
a route for Na+ ion influx, which is required for maintaining
[Na+]i at concentrations necessary for activity of the sodium
pump, suggests that the flux of Na+ ions through sodium chan-
nels may provide a feedback loop that, in turn, modulates the
ability of astrocytes to regulate K+ levels in the extracellular
space. It is not yet known whether sodium channels contribute
to the regulation of Na+/K+-ATPase activity in a similar manner
in other cell types.
Observations on T lymphocytes suggest that sodium channel
activity can trigger calcium signals, which, in turn, fine-tune
the effector functions of these cells. Sustained Ca2+ influx
has been shown to be required for the positive selection of
CD4+CD8+ T cells (Oh-hora, 2009). Recent work has demon-
strated the presence of Nav1.5 sodium channels in these cells
and has shown that blockade of these sodium channels with
TTX, or knockdown with shRNA, inhibits the induction of sus-
tained Ca2+ influx induced in CD4+CD8+ thymocytes by the posi-
tively selecting ligand (gp250-I-EK) and prevents the positive
selection of CD4+ T cells (Lo et al., 2012). Moreover, a gain-of-
function assay showed that ectopic expression of Nav1.5 chan-
nels in T cells obtained frommice with the transgenic expression
of a receptor specific to moth cytochrome c bound to major his-
tocompatibility complex (MHC) class II molecule I-EK (Lo et al.,
2009) (these mice do not normally express Nav1.5) endowsthese cells with an ability to respond appropriately to positively
selecting ligands, to which these cells do not normally respond
(Lo et al., 2012). Sodium channel activity thus appears to
contribute to Ca2+ influx after stimulation in these T cells and
thereby play a critical role in positive selection after challenge
byweak-signal ligands. How the Nav1.5 channels function within
these cells to trigger calcium signals is not yet known.
A role for sodium channels as a driver of reverse (Ca2+-import-
ing) Na/Ca exchange, which has been observed in multiple
nonexcitable cell types, including NG2 cells and astrocytes (Kir-
ischuk et al., 1997; Paluzzi et al., 2007; Tong et al., 2009), is
beginning to emerge as a common motif. The Na/Ca exchanger
can operate in forward mode by carrying Na+ ions down their
concentration gradient into cells and in return exporting Ca2+
or, if the cell is depolarized or the transmembrane gradient of
Na+ is reduced, can function in reverse mode by carrying Na+
ions out of the cell while importing Ca2+ (Annunziato et al.,
2004). In NG2 cells, which are sometimes referred to as oligo-
dendrocyte precursors cells, Tong et al. (2009) demonstrated
increased intracellular Na+ and Ca2+ levels, coincident with
membrane depolarization and enhanced migratory capacity of
the cells, that could be evoked by the application of GABA.
Blockade or knockdown of sodium channels by siRNA signifi-
cantly decreased the rise in [Ca2+]i and [Na
+]i, and attenuated
the migration of NG2 cells (Tong et al., 2009). Attenuated
[Ca2+]i and reduced cell migration were also observed after
siRNA knockdown of the Na/Ca exchanger or KB-R7943
blockade of reverse Na/Ca exchange. Thus, within NG2 cells,
Na+ flux through sodium channels, in this case triggered by
GABA, elicits reverse operation of the Na/Ca exchanger and
influx of Ca2+, resulting in increased [Ca2+]i affecting cellular
motility. A similar mechanism may operate in astrocytes.
Although astrocytes do not generate action potentials under
physiological conditions and have thus been considered to be
electrically inexcitable, Verkhratsky and Kettenmann (1996)—
noting that these cells can produce transient Ca2+ signals, which
can propagate aswaves—have used the term ‘‘Ca2+ excitability’’
to describe this phenomenon. Both forward and reverse opera-
tion of the Na/Ca exchanger have been described in astrocytes
(Kirischuk et al., 1997; Paluzzi et al., 2007), which, as a result ofNeuron 80, October 16, 2013 ª2013 Elsevier Inc. 285
Figure 3. Nav1.5 Colocalizes with Phagocytosed E. coli in Activated Macrophages
Sixtyminutes after bacterial challenge, Nav1.5 (green) and Texas-Red-labeled E. coliwere colocalized in a perinuclear region. The nucleus was stained with DAPI
(blue). (Modified from Figure 6B in Carrithers et al., 2007).
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Perspectivetheir membrane potential and intracellular level of Na+, are
poised close to the reversal potential of the Na/Ca exchanger,
which can therefore produce rapid, short-lived, and spatially
restricted Ca2+ signals (Kirischuk et al., 2012). The possibility
that activity of sodium channels can elicit reverse Na/Ca
exchange and modify cellular responses in astrocytes, and in
other cell types, is currently being examined.
A different role for sodium channels in the modulation of cell
motility is suggested by the intracellular localization of Nav1.6
near F-actin bundles in macrophages and melanoma cells in
areas of cell attachment, where a Nav1.6 splice variant regulates
cellular invasion via modulation of the formation of podosomes
(specialized F-actin zones, which mediate adhesion, invasion,
and migration) and invadopodia (Carrithers et al., 2009). Sodium
channel blockade with 0.3 mM TTX and Nav1.6 knockdown with
shRNA inhibit podosome formation and invasion through the
basement membrane matrix. Further implicating Nav1.6, podo-
some formation was also attenuated in macrophages obtained
from med mice. Activation of sodium channels with veratridine
triggered a shift of Na+ from cationic vesicular compartments
to mitochondria and a rise in intracellular Ca2+ in macrophages,
and blockade of themitochondrial Na/Ca exchanger significantly
reduced the veratridine-induced increase in [Ca2+]I within wild-
type macrophages, but not in macrophages from med mice.
Taken together, these observations suggest that Nav1.6
contributes—via a mechanism involving release of sodium
from vesicular intracellular stores, uptake by mitochondria, and
extrusion of Ca2+ from mitochondria—to the control of podo-
some and invadopodia formation and thereby regulates F-actin
cytoskeletal remodeling and movement of macrophages and
melanoma cells.
An added layer of complexity may arise from the fact that
sodium channels possess alternative splicing sites, many of
which are evolutionarily conserved and probably functionally
important (e.g., Plummer et al., 1997; Diss et al., 2004; Gazina
et al., 2010; Schroeter et al., 2010). The splice variants can
have distinct biophysical properties, which in some cases are
dependent on interactions with b-subunits (Farmer et al.,
2012). Neonatal splice variants of sodium channels have been286 Neuron 80, October 16, 2013 ª2013 Elsevier Inc.detected in multiple nonexcitable cells, including astrocytes
(Oh and Waxman, 1998), human macrophages (Carrithers
et al., 2009), and cancer cells (Fraser et al., 2005; Brackenbury
et al., 2007). Although the functional consequences of expres-
sion of these splice variants is not fully understood, it is known
that expression of the Nav1.5 neonatal splice variant potentiates
the invasiveness of breast cancer cells (Brackenbury et al.,
2007). Interestingly, alternative splicing of some sodium chan-
nels, such as Nav1.6, can produce truncated and presumably
nonconducting two-domain proteins, which are present in a
broad range of nonneuronal tissues (Plummer et al., 1997; Oh
and Waxman, 1998). It can also be speculated that further study
will uncover nonconducting roles for sodium channels, as has
been proposed for the autoregulation of transcription by the
C terminus of the L-type calcium channel Cav1.2 (Dolmetsch
et al., 2001; Gomez-Ospina et al., 2006; Satin et al., 2011) and
tumor progression by the potassium channel ether-a´-go-go
(Kv10.1) (Downie et al., 2008).
Perspectives: An Opportunity for Neuroscientists
It is now clear that many cell types traditionally considered non-
excitable express voltage-gated sodium channels. Moreover,
there is abundant evidence that blockade or knockdown of
sodium channel activity can significantly alter effector functions
and physiological responses of these nonexcitable cells. We do
not, at this time, have a full appreciation of the intracellular cas-
cades by which sodium channel activity contributes to signaling
pathways in nonexcitable cells. Data from recent studies sug-
gest that there are multiple intracellular molecular mechanisms
and provide hints that sodium channel activity in some cells
may amplify, localize, and/or fine-tune intracellular Ca2+ levels.
These studies also indicate that, in at least some cell types, the
activity of sodium channels localized within intracellular com-
partments, and not solely on the plasma membrane, can partic-
ipate in regulation of cellular functions.
Contributions of voltage-gated sodium channels to the func-
tion of nonexcitable cells should not be a surprise to neuro-
scientists. As a result of their voltage dependence and
kinetics, several sodium channels, notably Nav1.9 (Cummins
Figure 4. Schematic Showing Multiple
Modes of Participation of Sodium Channels
in Effector Functions of Nonexcitable Cells
(A) Nav1.5 expression within late endosomes of
macrophages contributed to the regulation of
acidification of endosomal lumina by counter-
balancing proton accumulation, thereby main-
taining electroneutrality. Endosomal sodium
channels became increasingly inactive with acid-
ification, providing a negative-feedback loop and
preventing cell injury.
(B) Expression and activity of sodium channels in
nonexcitable cells can lead to depolarized resting
membrane potential and modulation of multiple
effector functions.
(C) Expression of sodium channels in nonexcitable
astrocytes provides a route for Na+ influx, which
maintains [Na+]i at levels necessary for the activity
of the Na+/K+-ATPase.
(D) Activity of sodium channels in nonexcitable
cells results in Na+ influx and increased [Na+]I,
leading to reverse operation of the Na/Ca
exchanger and import of Ca2+ and modulation of
calcium signaling.
Table 3. Noncanonical Roles of Voltage-Gated SodiumChannels:
Unanswered Questions
What is the full array of cell types in which voltage-gated sodium
channels are expressed?
What is the spectrum of effector functions regulated by sodium
channels?
How do sodium channels accomplish their regulatory roles in
nonexcitable cells?
How do sodium channels contribute to disease pathophysiology of
nonexcitable cells?
Can sodium channels in nonexcitable cells be therapeutically
targeted?
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Perspectiveet al., 1999) and Nav1.7 (Cummins et al., 1998), participate in
electrogenesis in the subthreshold range, where they amplify
small depolarizations so as to bring the cell to the action-
potential threshold where other sodium channel subtypes
activate to produce the majority of the inward current respon-
sible for the depolarizing phase of the action potential.
Within the injured nervous system, persistent sodium currents,
even in resting axons, can trigger injurious Ca2+-importing
reverse Na/Ca exchange (Stys et al., 1992, 1993). However, in
contrast to the roles played by sodium channels in the
subthreshold domain in excitable cells (see Rush et al., 2007
for a review), the noncanonical roles of sodium channels, in
cell types traditionally viewed as nonexcitable, have been rela-
tively unexplored.
There is a world of sodium channel activity, within cells tradi-
tionally viewed as nonexcitable, that has been ‘‘below the sur-
face’’ to neuroscientists. Some of the unanswered questions
about the noncanonical roles of sodium channels are summa-
rized in Table 3. We need to know the full array of cell types in
which sodium channels are expressed and the full spectrum
of the functional roles of sodium channels in these cells. There
is a pressing need to understand the mechanisms by which
sodium channels exert their influences in these cells. It is clear,
from the roles of sodium channels in phagocytosis and their up-
regulation in glial cells in the injured nervous system, that these
channels are poised to contribute to disease pathophysiology,Neuron 80,but their precise contributions to the
functions of these, as well as other, cell
types in disease remains to be eluci-
dated. Finally, given that sodium chan-
nels are emerging as functional players
in nonexcitable cells in disease states,
we need to understand whether targeted
blockade or knockdown of sodium chan-
nel subtypes in specific cell types might
be of therapeutic value.Neuroscientists, armed with an array of methods for directly
monitoring channel activity by using electrophysiological, imag-
ing, or pharmacological techniques and with assays that permit
real-time assessment of intracellular [Na+] and [Ca2+], are in a
unique position to further elucidate the noncanonical roles of
voltage-gated sodium channels in cells that have traditionally
been considered nonexcitable. Many of these cell types interact,
directly or indirectly, with neurons. We predict that over the next
decade, neuroscientists will use tools already at their disposal to
expand our understanding of the ensemble of sodium-channel-
mediated mechanisms that contribute to the function of normal
and injured cells.October 16, 2013 ª2013 Elsevier Inc. 287
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